-
Police Investigate Bedford Parent for Hallway Incident After Playoff Loss
-
Joe Biden Makes Surprise Appearance at Trinity College Dublin for Hunter's Medal
-
Regal Cinemas Launches 4DX Screenings for 'Heated Rivalry' Amid Immersive Theater Trend
-
Bank of Korea Governor Shin Hyun-song Appointed First Asian Chair of BIS Payment Committee
-
Texas Car Buyers: Legal Remedies When a Defective Vehicle Isn't a 'Lemon'
-
Northern California Jewish Sports Hall of Fame Announces 2026 Inductees
-
Phil Spencer on Housing Market Fairness: How Buyers and Sellers Navigate Falling Prices
-
Readers Debate GTA 6 Spin-offs, Server Strain, and Warner Bros. Decline in Games Inbox
-
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
-
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
-
Kalm with Kava and Pū'iwa Farms Hawai'i Bring Fresh Frozen Hawaiian Kava to Market
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
SNZweig Forms AEC Industry Advisory Council
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Moderna to Present at Upcoming Conference in November 2026
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
Sinner ATP Finals favourite after brilliant and controversial year
Jannik Sinner is trying to end an eventful season in the perfect fashion as he returns to home soil as favourite for his first ATP Finals title.
Italian Sinner arrives in Turin at the end of a sensational season in which he was victorious at the Australian and US Opens -- his first Grand Slam triumphs -- and won five more ATP titles.
The 23-year-old is seeking a first ever title at the season-ending tournament in Turin and has come a long way since losing last year's final to Novak Djokovic, pushing on to become world number one and a national hero.
Sinner is the first ever Italian to top the men's world rankings and ended his country's 48-year men's Slam title drought, and he finished the "Race To Turin" with more than 10,330 points.
That total is more than 3,000 points more than his closest rival Alexander Zverev, highlighting just how dominant Sinner has been in 2024.
Sinner has however been dogged by controversy after twice testing positive for traces of the steroid clostebol in March but being allowed to continue playing.
He was initially cleared by the International Tennis Integrity Agency in August but at the end of September the World Anti-Doping Agency appealed, seeking a ban of up to two years.
"We don't know anything yet (about the appeal)," Sinner, who has denied any wrongdoing, told reporters on Thursday.
"It's not a pleasurable situation to be in but we remain optimists."
Fans in Turin will be hoping for another helping of Sinner's burgeoning rivalry with flamboyant Carlos Alacaraz, also a two-time Slam winner this year after he successfully defended his Wimbledon title and won at Roland Garros for the first time.
"It's difficult to talk about a rivalry when you're so young. We're two players who like to do battle," Sinner said.
"Being considered favourite is definitely different compared to last year but I'm going to have the same approach to the tournament."
With Djokovic pulling out of the Finals injured there will be no representative of tennis' "big four" of the 24-time Slam winner, Roger Federer, Rafael Nadal and Andy Murray for the first time since 2001.
Djokovic, 37, withdrew due to an "ongoing injury" which meant he would end a season without an ATP title for the first time in 18 years -- although he did win gold at the Paris Olympics -- and his absence feels like the latest step in a dragged out changing of the guard.
That ensured places for Casper Ruud, Andrey Rublev and Finals debutant Alex de Minaur, who will be Sinner's first opponent on Sunday night in the Ilie Nastase Group.
Sinner and Alcaraz look like being tennis' new dominant forces but it is Alcaraz who has had the better of their most recent meetings, winning all three matches between the pair in 2024 including in the French Open semi-finals.
Supporters hoping for a blockbuster clash between tennis' two biggest stars will have to hope they meet in the knockout stages as they were drawn in separate groups on Thursday.
Alcaraz begins his bid for a first Finals crown against Casper Ruud on Monday in the John Newcombe Group.
A.Moore--AT